157 related articles for article (PubMed ID: 1285949)
1. Muscarinic cholinergic receptor-mediated modulation on striatal c-fos mRNA expression induced by levodopa in rat brain.
Chou H; Ogawa N; Asanuma M; Hirata H; Mori A
J Neural Transm Gen Sect; 1992; 90(3):171-81. PubMed ID: 1285949
[TBL] [Abstract][Full Text] [Related]
2. Rapid response of striatal muscarinic M1-receptor mRNA to muscarinic cholinergic agents in rat brain.
Chou H; Ogawa N; Asanuma M; Hirata H; Kondo Y; Mori A
Brain Res Mol Brain Res; 1993 Aug; 19(3):211-4. PubMed ID: 8412562
[TBL] [Abstract][Full Text] [Related]
3. Effect of long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats.
Suga M
Life Sci; 1980 Sep; 27(10):877-82. PubMed ID: 7412476
[No Abstract] [Full Text] [Related]
4. Muscarinic, adenosine A(2) and histamine H(3) receptor modulation of haloperidol-induced c-fos expression in the striatum and nucleus accumbens.
Hussain N; Flumerfelt BA; Rajakumar N
Neuroscience; 2002; 112(2):427-38. PubMed ID: 12044460
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
[TBL] [Abstract][Full Text] [Related]
6. Coordinate expression of c-fos and jun B is induced in the rat striatum by cocaine.
Moratalla R; Vickers EA; Robertson HA; Cochran BH; Graybiel AM
J Neurosci; 1993 Feb; 13(2):423-33. PubMed ID: 8426221
[TBL] [Abstract][Full Text] [Related]
7. Co-stimulation of D(1)/D(5) and D(2) dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons.
Svenningsson P; Fredholm BB; Bloch B; Le Moine C
Neuroscience; 2000; 98(4):749-57. PubMed ID: 10891618
[TBL] [Abstract][Full Text] [Related]
8. Interactions between D1 and muscarinic receptors in the induction of striatal c-fos in rats depleted of dopamine as neonates.
Sandstrom MI; Sarter M; Bruno JP
Brain Res Dev Brain Res; 1996 Oct; 96(1-2):148-58. PubMed ID: 8922677
[TBL] [Abstract][Full Text] [Related]
9. Fos immunoreactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in the rat.
Bernard V; Dumartin B; Lamy E; Bloch B
Eur J Neurosci; 1993 Sep; 5(9):1218-25. PubMed ID: 8281324
[TBL] [Abstract][Full Text] [Related]
10. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum.
Steiner H; Gerfen CR
J Neurosci; 1993 Dec; 13(12):5066-81. PubMed ID: 7504719
[TBL] [Abstract][Full Text] [Related]
11. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat.
Bronstein DM; Ye H; Pennypacker KR; Hudson PM; Hong JS
Brain Res Mol Brain Res; 1994 May; 23(3):191-203. PubMed ID: 7914658
[TBL] [Abstract][Full Text] [Related]
12. L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset.
Svenningsson P; Gunne L; Andren PE
Neuroscience; 2000; 99(3):457-68. PubMed ID: 11029538
[TBL] [Abstract][Full Text] [Related]
13. Age-related decrements in the muscarinic enhancement of K+-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence.
Joseph JA; Dalton TK; Hunt WA
Brain Res; 1988 Jun; 454(1-2):140-8. PubMed ID: 2900662
[TBL] [Abstract][Full Text] [Related]
14. Differential Expression of Striatal ΔFosB mRNA and FosB mRNA After Different Levodopa Treatment Regimens in a Rat Model of Parkinson's Disease.
Palafox-Sanchez V; Sosti V; Ramirez-García G; Kulisevsky J; Aguilera J; Limón ID
Neurotox Res; 2019 Apr; 35(3):563-574. PubMed ID: 30645726
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with antipsychotics does not alter the phosphoinositide response to muscarinic or D2 dopaminergic agonists in rat striatum.
Rubinstein JE; Hitzemann RJ; Ashby CR; Wang RY
Brain Res; 1989 Sep; 496(1-2):385-8. PubMed ID: 2572294
[TBL] [Abstract][Full Text] [Related]
16. Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa.
Asin KE; Bednarz L; Nikkel A; Perner R
J Pharmacol Exp Ther; 1995 Jun; 273(3):1483-90. PubMed ID: 7791123
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic administration of haloperidol (intermittently) and haloperidol-decanoate (continuously) on D2 dopamine and muscarinic cholinergic receptors and on carbachol-stimulated phosphoinositide hydrolysis in the rat striatum.
Akiyama K; Sato M; Yamada N; Otsuki S
Jpn J Psychiatry Neurol; 1987 Jun; 41(2):311-20. PubMed ID: 2830427
[TBL] [Abstract][Full Text] [Related]
18. Role of dopamine D1 receptors in the striatal and cortical fos expression induced by the muscarinic agonist pilocarpine.
Wirtshafter D
Eur J Pharmacol; 2004 Mar; 488(1-3):85-90. PubMed ID: 15044039
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of muscarinic receptors induces expression of individual fos and jun genes through different transduction pathways.
Ding WQ; Larsson C; Alling C
J Neurochem; 1998 Apr; 70(4):1722-9. PubMed ID: 9523591
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats.
Morelli M; Pinna A; Fenu S; Carta A; Cozzolino A; Di Chiara G
Synapse; 1994 Dec; 18(4):288-93. PubMed ID: 7886620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
